Bioventix (LSE:BVXP) — Stock Price
Bioventix (LSE:BVXP) is currently trading at GBX1500.00 GBX, down 0.66% today. Over the past 52 weeks, shares have ranged between GBX1375.00 and GBX2525.00. This page tracks Bioventix's live share price on the LSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Bioventix worth.
Bioventix (BVXP) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Bioventix's daily closing share price and trading volume on the LSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Bioventix Income Statement — Revenue, Profit & Earnings by Year
Bioventix's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | GBX13.12 Million | GBX13.61 Million | GBX12.82 Million | GBX11.72 Million | GBX10.93 Million |
| Cost of Revenue | GBX1.20 Million | GBX925.53K | GBX957.64K | GBX853.84K | GBX952.55K |
| Gross Profit | GBX11.92 Million | GBX12.68 Million | GBX11.86 Million | GBX10.87 Million | GBX9.98 Million |
| Research & Development | GBX1.49 Million | GBX999.42K | GBX1.20 Million | GBX975.32K | GBX1.20 Million |
| SG&A | GBX2.05 Million | GBX1.99 Million | GBX1.77 Million | GBX1.61 Million | GBX1.51 Million |
| Total Operating Expenses | GBX2.01 Million | GBX2.10 Million | GBX1.81 Million | GBX1.71 Million | GBX1.63 Million |
| Operating Income | GBX9.90 Million | GBX10.60 Million | GBX10.04 Million | GBX9.27 Million | GBX8.09 Million |
| EBITDA | GBX10.17 Million | GBX10.74 Million | GBX10.20 Million | GBX9.42 Million | GBX8.22 Million |
| EBIT | GBX10.07 Million | GBX10.63 Million | GBX10.07 Million | GBX9.28 Million | GBX8.09 Million |
| Interest Expense | — | — | GBX0.00 | GBX303.00 | GBX263.42K |
| Income Before Tax | GBX10.10 Million | GBX10.57 Million | GBX10.11 Million | GBX9.26 Million | GBX8.09 Million |
| Income Tax Expense | GBX2.51 Million | GBX2.48 Million | GBX1.74 Million | GBX1.60 Million | GBX1.39 Million |
| Net Income | GBX7.58 Million | GBX8.10 Million | GBX8.37 Million | GBX7.67 Million | GBX6.73 Million |
Bioventix Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Bioventix's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | GBX12.86 Million | GBX13.73 Million | GBX13.28 Million | GBX13.12 Million | GBX12.91 Million |
| Total Current Assets | GBX12.03 Million | GBX12.83 Million | GBX12.10 Million | GBX11.81 Million | GBX11.45 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | GBX6.24 Million | GBX6.21 Million | GBX5.81 Million | GBX5.22 Million | GBX4.63 Million |
| Inventory | GBX689.40K | GBX615.35K | GBX565.37K | GBX461.81K | GBX332.46K |
| Property, Plant & Equipment | — | — | — | GBX694.37K | GBX843.72K |
| Goodwill | — | — | — | — | — |
| Total Liabilities | GBX1.31 Million | GBX1.73 Million | GBX1.22 Million | GBX1.30 Million | GBX1.09 Million |
| Total Current Liabilities | GBX1.31 Million | GBX1.73 Million | GBX1.20 Million | GBX1.25 Million | GBX1.01 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | GBX-5.08 Million | GBX-6.00 Million | GBX-5.72 Million | GBX-6.13 Million | GBX-6.49 Million |
| Total Stockholder Equity | GBX11.55 Million | GBX12.00 Million | GBX12.06 Million | GBX11.82 Million | GBX11.82 Million |
| Retained Earnings | GBX9.75 Million | GBX10.27 Million | GBX10.33 Million | GBX10.23 Million | GBX10.23 Million |
Bioventix Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Bioventix generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | GBX7.03 Million | GBX8.34 Million | GBX7.90 Million | GBX7.56 Million | GBX6.37 Million |
| Capital Expenditures | GBX19.19K | GBX15.91K | GBX10.58K | GBX11.76K | GBX260.33K |
| Free Cash Flow | GBX7.01 Million | GBX8.33 Million | GBX7.89 Million | GBX7.55 Million | GBX6.11 Million |
| Investing Cash Flow | GBX173.16K | GBX186.06K | GBX90.51K | GBX-11.76K | GBX-259.83K |
| Financing Cash Flow | GBX-8.12 Million | GBX-8.25 Million | GBX-8.30 Million | GBX-7.92 Million | GBX-7.69 Million |
| Dividends Paid | GBX8.19 Million | GBX8.25 Million | GBX8.44 Million | GBX7.92 Million | GBX7.71 Million |
| Stock-Based Compensation | GBX89.22K | GBX89.22K | GBX174.08K | GBX244.87K | GBX257.63K |
| Depreciation | GBX92.83K | GBX113.64K | GBX129.23K | GBX143.39K | GBX135.10K |
| Change in Cash | GBX-919.66K | GBX283.13K | GBX-410.83K | GBX-368.33K | GBX-1.58 Million |
Bioventix Earnings History — EPS Actual vs. Analyst Estimates
Track Bioventix's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 30, 2026 | — | — | — |
| Nov 11, 2025 | 0.72 | 0.78 | -7.69% |
| Mar 31, 2025 | 0.71 | 0.00 | — |
| Mar 27, 2023 | 0.71 | — | — |
| Oct 24, 2022 | 0.89 | — | — |
| Mar 30, 2022 | 0.57 | — | — |
| Oct 18, 2021 | 0.69 | — | — |
| Mar 29, 2021 | 0.59 | 0.00 | — |